FDA Leaders Outline How AI Is Shaping The Agency's Work
By Dan McKay · May 12, 2026, 2:16 PM EDT
The U.S. Food and Drug Administration is using generative artificial intelligence to help redact records before public release, summarize documents and evaluate scientific literature, federal officials said in a recent conference....
To view the full article, register now.